Arkolith/Insider Trading/ABCL/Form 4

Hayden Michael R

DirectorAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Sep 26, 2023
Net Buying
Open-Market Buys
$98K
Open-Market Sells
$0
Net Open-Market Flow
$98K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 22, 2023Buy(P)20K$4.91$98K1.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001703057-23-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML